Terms: = Cervical cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Prognosis
22 results:
1. Invasive stratified mucin-producing carcinoma (ISMC) of the cervix: a clinicopathological and molecular analysis of 59 cases with special emphasis on histogenesis and potential therapeutic targets.
Yao Y; Wang Y; Ye L; Lu B; Lu W
Histopathology; 2024 Jan; 84(2):315-324. PubMed ID: 37735961
[TBL] [Abstract] [Full Text] [Related]
2. Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer.
Kitazawa S; Chiyoda T; Nakamura K; Sakai K; Yoshihama T; Nishio H; Kobayashi Y; Iwata T; Banno K; Yamagami W; Nishihara H; Aoki D
Int J Clin Oncol; 2023 Nov; 28(11):1554-1562. PubMed ID: 37574505
[TBL] [Abstract] [Full Text] [Related]
3.
Flores Legarreta A; Salvo G; Gonzales NR; Chisholm G; Hillman RT; Frumovitz M
J Gynecol Oncol; 2023 Jul; 34(4):e50. PubMed ID: 36807750
[TBL] [Abstract] [Full Text] [Related]
4. Disease progression role as well as the diagnostic and prognostic value of microRNA-21 in patients with cervical cancer: A systematic review and meta-analysis.
Gebrie A
PLoS One; 2022; 17(7):e0268480. PubMed ID: 35895593
[TBL] [Abstract] [Full Text] [Related]
5. TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer.
Kuno I; Takayanagi D; Asami Y; Murakami N; Matsuda M; Shimada Y; Hirose S; Kato MK; Komatsu M; Hamamoto R; Okuma K; Kohno T; Itami J; Yoshida H; Shiraishi K; Kato T
Sci Rep; 2021 Sep; 11(1):19261. PubMed ID: 34584128
[TBL] [Abstract] [Full Text] [Related]
6. LINC00861 inhibits the progression of cervical cancer cells by functioning as a ceRNA for miR‑513b‑5p and regulating the pten/AKT/mTOR signaling pathway.
Liu H; Zhang L; Ding X; Sui X
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179755
[TBL] [Abstract] [Full Text] [Related]
7. LINC00673 exerts oncogenic function in cervical cancer by negatively regulating miR-126-5p expression and activates pten/PI3K/AKT signaling pathway.
Shi WJ; Liu H; Ge YF; Wu D; Tan YJ; Shen YC; Wang H; Xu H
Cytokine; 2020 Dec; 136():155286. PubMed ID: 32950808
[TBL] [Abstract] [Full Text] [Related]
8. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer.
Zhang X; Liu S; Zhu Y
Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379
[TBL] [Abstract] [Full Text] [Related]
9. LHPP suppresses proliferation, migration, and invasion and promotes apoptosis in pancreatic cancer.
Wu F; Chen Y; Zhu J
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32186702
[TBL] [Abstract] [Full Text] [Related]
10. Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patients.
Hirose S; Murakami N; Takahashi K; Kuno I; Takayanagi D; Asami Y; Matsuda M; Shimada Y; Yamano S; Sunami K; Yoshida K; Honda T; Nakahara T; Watanabe T; Komatsu M; Hamamoto R; Kato MK; Matsumoto K; Okuma K; Kuroda T; Okamoto A; Itami J; Kohno T; Kato T; Shiraishi K; Yoshida H
Gynecol Oncol; 2020 Jan; 156(1):203-210. PubMed ID: 31757465
[TBL] [Abstract] [Full Text] [Related]
11. Genomic characterization of cervical cancer based on human papillomavirus status.
Zhang L; Jiang Y; Lu X; Zhao H; Chen C; Wang Y; Hu W; Zhu Y; Yan H; Yan F
Gynecol Oncol; 2019 Mar; 152(3):629-637. PubMed ID: 30581036
[TBL] [Abstract] [Full Text] [Related]
12. Identification of CD28 and pten as novel prognostic markers for cervical cancer.
Shen F; Zheng H; Zhou L; Li W; Liu J; Xu X
J Cell Physiol; 2019 May; 234(5):7004-7011. PubMed ID: 30362552
[TBL] [Abstract] [Full Text] [Related]
13. Putative biomarkers for cervical cancer: SNVs, methylation and expression profiles.
Cardoso MFS; Castelletti CHM; Lima-Filho JL; Martins DBG; Teixeira JAC
Mutat Res Rev Mutat Res; 2017 Jul; 773():161-173. PubMed ID: 28927526
[TBL] [Abstract] [Full Text] [Related]
14. Somatic Host Cell Alterations in HPV Carcinogenesis.
Litwin TR; Clarke MA; Dean M; Wentzensen N
Viruses; 2017 Aug; 9(8):. PubMed ID: 28771191
[TBL] [Abstract] [Full Text] [Related]
15. Polyvalent Folate-Dendrimer-Coated Iron Oxide Theranostic Nanoparticles for Simultaneous Magnetic Resonance Imaging and Precise cancer Cell Targeting.
Luong D; Sau S; Kesharwani P; Iyer AK
Biomacromolecules; 2017 Apr; 18(4):1197-1209. PubMed ID: 28245646
[TBL] [Abstract] [Full Text] [Related]
16. [Relationships between microRNA expressions and prognosis in patients with tongue squamous cell carcinoma and the mechanisms microRNA regulating tongue squamous cell carcinoma biological behavior].
Jia LF; Gan YH; Yu GY
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):5-9. PubMed ID: 26885901
[TBL] [Abstract] [Full Text] [Related]
17. CD10 expression in the neuroendocrine carcinoma component of endometrial mixed carcinoma: association with long survival.
Uehara K; Ikehara F; Tanabe Y; Nakazato I; Oshiro M; Inamine M; Kinjo T
Diagn Pathol; 2016 Feb; 11():16. PubMed ID: 26830028
[TBL] [Abstract] [Full Text] [Related]
18. MicroRNA-494 promotes cervical cancer proliferation through the regulation of pten.
Yang YK; Xi WY; Xi RX; Li JY; Li Q; Gao YE
Oncol Rep; 2015 May; 33(5):2393-401. PubMed ID: 25738254
[TBL] [Abstract] [Full Text] [Related]
19. Designing a high-throughput somatic mutation profiling panel specifically for gynaecological cancers.
Spaans VM; Trietsch MD; Crobach S; Stelloo E; Kremer D; Osse EM; Haar NT; van Eijk R; Muller S; van Wezel T; Trimbos JB; Bosse T; Smit VT; Fleuren GJ
PLoS One; 2014; 9(3):e93451. PubMed ID: 24671188
[TBL] [Abstract] [Full Text] [Related]
20. Expression of pten and survivin in cervical cancer: promising biological markers for early diagnosis and prognostic evaluation.
Lu D; Qian J; Yin X; Xiao Q; Wang C; Zeng Y
Br J Biomed Sci; 2012; 69(4):143-6. PubMed ID: 23310986
[TBL] [Abstract] [Full Text] [Related]
[Next]
